Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Brain training for epilepsy: new hope for memory and mood

NCT ID NCT05934786

Symptom relief Sponsor: Vilnius University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests a cognitive rehabilitation program for adults with epilepsy. The program includes six one-on-one therapy sessions and two group sessions over two months, focusing on memory strategies, coping skills, and social support. Researchers will measure changes in quality of life, memory, and mood in 70 participants.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
cognitive rehabilitation therapy
What this could lead to
If it works, this could provide an evidence-based therapy to help people with epilepsy manage memory problems and improve their daily well-being.
What could go wrong
This is a small, early-stage trial with only 70 participants. The intervention is behavioral, so results may vary widely and may not apply to everyone with epilepsy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 70 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2023

Expected to finish

Nov 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Active epilepsy (medication for epilepsy and/or had at least one seizure in the past year) * Adults (\>17 years) * Lithuanian speaker * No intellectual disability Exclusion Criteria: * Sensory or motor deficit preventing task completion * Epilepsy surgery planned during the project * Active non-paroxysmal comorbid disorder of the central nervous system (e.g., * neurodegeneration, multiple sclerosis) * Active psychiatric disorder during the past year * Psychoactive substance use (except social alcohol, tobacco and caffeine use)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Epilepsy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

epilepsy Psychological Well-Being

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Epilepsy

Contacts and locations

Locations

  • Vilnius University Hospital Santaros Klinikos

    Vilnius, Lithuania

More trials for these conditions

Other studies related to the condition(s) this trial covers.